Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis. | Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis. Makinoya M, Miyatani K, Matsumi Y, Sakano Y, Shimizu S, Shishido Y, Hanaki T, Kihara K, Matsunaga T, Yamamoto M, Tokuyasu N, Takano S, Sakamoto T, Hasegawa T, Saito H, Nakayama Y, Osaki M, Okada F, Fujiwara Y., Free PMC Article | 05/22/2024 |
Expression and significant roles of the lncRNA NEAT1/miR-493-5p/Rab27A axis in ulcerative colitis. | Expression and significant roles of the lncRNA NEAT1/miR-493-5p/Rab27A axis in ulcerative colitis. Wang H, Teng J, Wang M, Zhang Y, Liu X, Liu Z., Free PMC Article | 05/31/2023 |
Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma. | Cancer-associated fibroblasts promote tumor cell growth via miR-493-5p in intrahepatic cholangiocarcinoma. Toshida K, Itoh S, Harada N, Morinaga A, Yugawa K, Tomiyama T, Kosai-Fujimoto Y, Tomino T, Kurihara T, Nagao Y, Morita K, Oda Y, Yoshizumi T., Free PMC Article | 03/13/2023 |
Propofol-Induced miR-493-3p Inhibits Growth and Invasion of Gastric Cancer through Suppression of DKK1-Mediated Wnt/beta-Catenin Signaling Activation. | Propofol-Induced miR-493-3p Inhibits Growth and Invasion of Gastric Cancer through Suppression of DKK1-Mediated Wnt/β-Catenin Signaling Activation. Zhan K, Song X, Zhang Q, Yang J, Lu S., Free PMC Article | 02/13/2023 |
LINC00324 promotes cell proliferation and metastasis of esophageal squamous cell carcinoma through sponging miR-493-5p via MAPK signaling pathway. | LINC00324 promotes cell proliferation and metastasis of esophageal squamous cell carcinoma through sponging miR-493-5p via MAPK signaling pathway. Sharma U, Kaur Rana M, Singh K, Jain A. | 02/4/2023 |
Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis. | Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3/MYC axis. Wang A, Chen Y, Shi L, Li M, Li L, Wang S, Wang C., Free PMC Article | 07/2/2022 |
Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30. | Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30. Liu Q, Yang H, Hua H. | 06/18/2022 |
ILF3-AS1 promotes the aerobic glycolysis and proliferation of melanoma cells by regulating miR-493-5p/PDK1 pathway. | ILF3-AS1 promotes the aerobic glycolysis and proliferation of melanoma cells by regulating miR-493-5p/PDK1 pathway. Huang WQ, Zhuang QR, He ZJ. | 04/23/2022 |
Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation. | Circ-CSPP1 knockdown suppresses hepatocellular carcinoma progression through miR-493-5p releasing-mediated HMGB1 downregulation. Yang G, Xu Q, Wan Y, Zhang L, Wang L, Meng F. | 04/9/2022 |
SNHG1 functions as an oncogenic lncRNA and promotes osteosarcoma progression by up-regulating S100A6 via miR-493-5p. | SNHG1 functions as an oncogenic lncRNA and promotes osteosarcoma progression by up-regulating S100A6 via miR-493-5p. Liu Q, Luo J, Wang H, Zhang L, Jin G., Free PMC Article | 04/2/2022 |
MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways. | MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways. Liu H, Li Z, Sun H. | 03/12/2022 |
Circular RNA circPRKDC promotes tumorigenesis of gastric cancer via modulating insulin receptor substrate 2 (IRS2) and mediating microRNA-493-5p. | Circular RNA circPRKDC promotes tumorigenesis of gastric cancer via modulating insulin receptor substrate 2 (IRS2) and mediating microRNA-493-5p. Liu Z, Wang Y, Ding Y., Free PMC Article | 02/26/2022 |
Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. | Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Feng N, Guo Z, Wu X, Tian Y, Li Y, Geng Y, Yu Y., Free PMC Article | 02/12/2022 |
miR-493 by regulating of c-Jun targets Wnt5a/PD-L1-inducing esophageal cancer cell development. | miR-493 by regulating of c-Jun targets Wnt5a/PD-L1-inducing esophageal cancer cell development. Bian W, Li Y, Zhu H, Gao S, Niu R, Wang C, Zhang H, Qin X, Li S., Free PMC Article | 12/25/2021 |
Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis. | Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis. Wang J, Liu Y, Cai H, Jiang H, Li W, Shi Y., Free PMC Article | 12/18/2021 |
Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis. | Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis. Cui F, Luo P, Bai Y, Meng J., Free PMC Article | 11/27/2021 |
Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p/TRIM2 axis. | Long non-coding RNA NR2F1-AS1 promoted neuroblastoma progression through miR-493-5p/TRIM2 axis. Liu L, Zhao H, He HH, Huang J, Xu YY, Li XL, Wu Y, Wang J, Zhu YB. | 07/3/2021 |
Lung cancerassociated transcript 1 facilitates tumorigenesis in laryngeal squamous cell carcinoma through the targeted inhibition of miR493. | Lung cancer‑associated transcript 1 facilitates tumorigenesis in laryngeal squamous cell carcinoma through the targeted inhibition of miR‑493. Zhao Z, Xing Y, Liu Y, Jing S., Free PMC Article | 04/17/2021 |
MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway. | MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway. Cui FC, Chen Y, Wu XY, Hu M, Qin WS. | 04/3/2021 |
MiR-493 Induces Cytotoxic Autophagy in Prostate Cancer Cells through Regulation on PHLPP2. | MiR-493 Induces Cytotoxic Autophagy in Prostate Cancer Cells through Regulation on PHLPP2. Deng J, Ma M, Jiang W, Zheng L, Cui S. | 01/9/2021 |
Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4. | Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4. Li W, Jin X, Zhao Y, Dai J, Cai Y. | 12/19/2020 |
LINC01605 promotes the proliferation of laryngeal squamous cell carcinoma through targeting miR-493-3p. | LINC01605 promotes the proliferation of laryngeal squamous cell carcinoma through targeting miR-493-3p. Wang XY, Wang L, Xu PC, Huang FJ, Jian X, Wei ZC, Chen YQ. | 10/24/2020 |
Molecular Mechanisms and Therapeutic Potential of miR-493 in Cancer. | Molecular Mechanisms and Therapeutic Potential of miR-493 in Cancer. Huang L, Huang L, Li Z, Wei Q. | 09/19/2020 |
miR-493-5p mediated part of its tumor-suppressor activity by abrogating overexpression of insulin-like growth factor 2 (IGF2) and the IGF2-derived intronic oncomir miR-483-3p in hepatocellular carcinoma cells characterized by IGF2 loss of imprinting. | MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells. Gailhouste L, Liew LC, Yasukawa K, Hatada I, Tanaka Y, Kato T, Nakagama H, Ochiya T., Free PMC Article | 08/12/2020 |
MYCN expression levels were inversely correlated with miR-493-5p in tumor tissues. | MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion. Yasukawa K, Liew LC, Hagiwara K, Hironaka-Mitsuhashi A, Qin XY, Furutani Y, Tanaka Y, Nakagama H, Kojima S, Kato T, Ochiya T, Gailhouste L., Free PMC Article | 03/21/2020 |